Public procurement notice: Contract Notice
Published: 2019-07-31
Buyer: HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (‘UHCW’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 09343000 | 09344000 | 33151000: Radiotherapy devices and supplies
Estimated value: 50000000 GBP
Submission deadline: 2019-08-29
Award criteria: The most economic tender

Technical requirements: HealthTrust Europe is seeking to establish a multi-lot framework agreement for the supply of radiopharmaceuticals (radioactive sterile and non-sterile drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases). Suppliers must possess the ability and the licence to compound, store, transport and deliver these goods.
Goods include medicines, radionuclide generators, preparation kits and associated accessories used for protection when handling, transporting and administering radiopharmaceuticals. The framework will also include the preparation and supply of bespoke radiopharmaceuticals for specific patients as a separate lot.
HealthTrust Europe is seeking to establish a multi-lot framework agreement for the supply of radiopharmaceuticals (radioactive sterile and non-sterile drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases) and consumables.
In order to be successfully awarded to Lot 1, suppliers must must possess the ability and the licences to compound, store, transport and deliver radiopharmaceutical goods, which shall include nuclear medicines, radionuclide generators, preparation kits and associated accessories used for protection purposes during the handling, transportation and administration of radiopharmaceuticals.
Suppliers must possess the ability and all applicable licences to obtain, store and deliver and dispose of radiopharmaceutical goods in accordance with legislation, regulation and procedural best practice.
Terms and conditions/activity based income (ABI): the terms and conditions of this framework agreement and any resulting call-off contract is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this framework agreement, the management and administration by HTE of the overall contract structure and associated documentation, as well as the requirement to submit regular management information to HTE.
Submission of expressions of interest and procurement information: this exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows:
— click the SQs/ITTs open to all suppliers link. These are the SQs/ITTs open to any registered supplier,
— click the express interest button at the top of the page. This will move the SQ/ITT into your My SQs/My ITTs page. You can access any attachments by clicking buyer attachments in the SQ/ITT Details box,
— submit your reply using the submit response button at the top of the page. If you require any further advice, contact the Bravo e- Tendering Help Desk at help@bravosolution.co.uk
Sid4Gov HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at sid4gov@gps.gsi.gov.uk
Please note that sid4gov does not pre-populate any fields of the SQ on HTE's Bravo portal. Candidates must complete the qualification and technical envelopes of the SQ in Bravo in full.
The framework agreement resulting from this procurement process will remain in force for an initial period of 36 months and subject to approval by HealthTrust Europe may be extended for a further 12 month period thereafter.
HealthTrust Europe (HTE) is seeking to establish a multi-lot framework agreement for the supply of radiopharmaceuticals (radioactive sterile and non-sterile drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases).

Eligibility requirements: HTE may request such information as may be requested pursuant to Regulation 58 of the Public Contracts Regulations 2015.

Award value: 50000000